Zacks Small Cap Research – WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones – Go Health Pro

Zacks Small Cap Research – WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones – Go Health Pro

By M. Marin NASDAQ:WINT Lead Drug Candidates, New Phase 2b Clinical Trial Data, Multiple Programs Focus on Unmet Needs In Cardiogenic Shock & AHF Pennsylvania-based Windtree Therapeutics, Inc. (NASDAQ:WINT) is a biopharmaceutical company developing therapies for a range of cardiovascular and oncology treatments characterized by significant unmet need. The company’s lead indication area is cardiogenic … Read more

More Details on Israel Sabotaging Hezbollah Pagers and Walkie-Talkies – Go Health Pro

More Details on Israel Sabotaging Hezbollah Pagers and Walkie-Talkies The Washington Post has a long and detailed story about the operation that’s well worth reading (alternate version here). The sales pitch came from a marketing official trusted by Hezbollah with links to Apollo. The marketing official, a woman whose identity and nationality officials declined to … Read more

Some hurricane Milton cat bond losses likely, but uncertainty over aggregate structures: Icosa – Go Health Pro

Some hurricane Milton cat bond losses likely, but uncertainty over aggregate structures: Icosa – Go Health Pro

Catastrophe bond fund manager Icosa Investments has highlighted current uncertainty over the level of losses the market may face from hurricane Milton, but notes that while some principal losses seem likely there remains a high level of uncertainty over certain structures, especially aggregate cat bonds that have much of their risk periods left to run.The … Read more

x